Avalyn Pharma Inc. Common Stock

The current price of AVLN is $27.47 — it has increased by 2.46% since the previous close. Data as of Nov 4, 2026.

AVLN is up 6.85% over the past week, down 2.35% over the past month and down 6.85% over the past year. The price is below its 200-day moving average of $29.94.

Analysts' average 12-month price target for AVLN is $60.00, which implies 118.42% upside from the current price. Individual estimates range from $51.00 to $80.00.

Of the 5 analysts covering Avalyn Pharma Inc. Common Stock, 2 rate it a strong buy and 3 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Avalyn Pharma Inc. Common Stock has a market capitalization of $1.22B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Avalyn Pharma Inc. Common Stock posted a loss of $0.98 per share against an estimate of -$0.7767, missing expectations by 26.18%. Upcoming reports are listed in the earnings calendar.

Companies most comparable to Avalyn Pharma Inc. Common Stock include Insmed Incorporated, MannKind Corporation, Gyre Therapeutics, Inc., Vicore Pharma Holding AB and Pulmatrix, Inc.

In the latest trading session AVLN moved between $26.03 and $28.35, a range of 8.46% of its current price.

Over the past 52 weeks AVLN has traded between $22.24 and $40.17. The current price is 31.62% below its 52-week high.